#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital disorder of glycosylation Small for dates baby Ichthyosis Dedifferentiated liposarcoma Mantle cell lymphoma stage II T-cell lymphoma Ventricular tachycardia Philadelphia positive acute lymphocytic leukaemia Spina bifida Precursor T-lymphoblastic lymphoma/leukaemia recurrent Chronic graft versus host disease in liver Soft tissue necrosis Haemophilia A without inhibitors Squamous cell carcinoma of head and neck Alport's syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Life with Disease Inclusion body myositis Pulmonary sarcoidosis – Basic Information Factor IX deficiency – Diagnostics Lymphangiosarcoma Retinitis pigmentosa Chondrosarcoma – Diagnostics Hepatic angiosarcoma – Life with Disease Basal cell naevus syndrome – Diagnostics Hyperoxaluria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    YL201 Darovasertib Eplerenone Mdna11 Sar-443579 Lactose Monohydrate Lactose Evg321 Lactulose Poa Pratensis Pollen Extract Pyridoxine Fludrocortisone Siplizumab Adrenaline Tartrate Ph. Eur. Lisinopril Nilutamide Marstacimab Rmc-6291 Montelukast Sodium Follitropin Beta More therapies…

    Learn about Your Condition

    Small intestine carcinoma Primary amyloidosis Biliary tract operation Abdominal wall pain Herpes simplex reactivation Nephrotic syndrome Choroidal dystrophy Tympanic membrane hyperaemia Aplastic anaemia Post procedural infection Osteosarcoma Cholangitis sclerosing Meningioma malignant Malabsorption Graft versus host disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ibuprofen Lysine
    • Modified Messenger Ribonucleic Acid Encoding Human Propionyl-Coenzyme A Carboxylase Alpha And Beta Subunits Encapsulated Into Lipid Nanoparticles
    • Pseudoephedrine Hydrochloride
    France Italy The Netherlands Spain

  • Study on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation

    Not recruiting

    3 1
    Investigated Diseases:
    • Palpitations
    • Atrial fibrillation
    • Obesity
    Investigated Drugs:
    • Semaglutide
    The Netherlands

  • Study of REGN7257 for Adults with Severe Aplastic Anemia Unresponsive to or Relapsed After Immunosuppressive Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Aplastic anaemia
    Investigated Drugs:
    • Regn7257
    France

  • Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Austria Czechia Greece The Netherlands Portugal Romania

  • Study on Oral Glibenclamide for Managing High Blood Sugar in Premature Infants Weighing Less Than 1500g

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neonatal hyperglycaemia
    Investigated Drugs:
    • Glibenclamide
    France

  • Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteopenia
    • Type 1 diabetes mellitus
    • Diabetes mellitus
    Investigated Drugs:
    • Alendronate Sodium Monohydrate
    Denmark
Previous Page
1 … 49 50 51 52 53 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!